Congenital hypothyroidism (CH) is one of the most common preventable causes of mental retardation. Obvious manifestations of hypothyroidism are not typically present at birth, meaning that clinical diagnosis is usually delayed until 3 months of age or older. Unfortunately, by the time the diagnosis is suspected, the effects of thyroid deficiency on the developing brain are irreversible. A study from Pittsburgh Children 's Hospital in 1972 reported that infants diagnosed between birth and 3 months of age had a mean IQ of 89 (range 64-107). However, if clinical diagnosis was made between 3 and 6 months of age, the mean IQ dropped to 71 (range 35-96), whilst in cases where diagnosis was delayed to beyond 6 months of age, the mean IQ was 54 (range 25-80).
Congenital hypothyroidism (CH) is one of the most common preventable causes of mental retardation. Obvious manifestations of hypothyroidism are not typically present at birth, meaning that clinical diagnosis is usually delayed until 3 months of age or older. Unfortunately, by the time the diagnosis is suspected, the effects of thyroid deficiency on the developing brain are irreversible. A study from Pittsburgh Children's Hospital in 1972 reported that infants diagnosed between birth and 3 months of age had a mean IQ of 89 (range 64-107). However, if clinical diagnosis was made between 3 and 6 months of age, the mean IQ dropped to 71 (range 35-96), whilst in cases where diagnosis was delayed to beyond 6 months of age, the mean IQ was 54 (range 25-80). 1 With recognition of the importance of early diagnosis and treatment, pilot programs to detect CH were undertaken in the mid-1970s. 2 Early on, most newborn screening (NBS) programs measured T4 in the heel-prick dried blood spot specimen, with a 'reflex' thyroid-stimulating hormone (TSH) determination on babies with a T4 below a specified cutoff, usually <10th percentile. With improvement of TSH assay sensitivity, many programs in the US and worldwide now perform an initial TSH screening test. 3 Based on clinical diagnosis, the incidence of CH in the pre-NBS era was reported to be 1:7,000. 4 Early in the NBS era, the incidence increased to 1:4,000. 5 Changes in the screening algorithm, primarily the lowering of the TSH cutoff, led to an increase in the incidence to 1:2,000. Estimates have been made of the economic benefit of early detection and treatment of neonates with CH. Such benefits include averted costs of institutionalization and special education, as well as increased productivity.
In 1977, the US Federal General Accounting Office estimated the lifetime
